Newly released findings of a multinational survey conducted on behalf of the International Osteoporosis Foundation (IOF) show clear disparities between patients' and doctors' perceptions of osteoporosis and its management. Bone health experts attending the 1st Asia-Pacific Osteoporosis Meeting in Singapore this week have flagged vitamin D deficiency as a major concern in the region, particularly in South Asia where the problem is especially severe and widespread across the entire population. For years, it was believed that obese women were at lower risk for developing osteoporosis, and that excess body fat actually protected against bone loss. A recent study by researchers from Kings’ college, London reveals that people with more than 100 moles on their body have less chance of osteoporosis or brittle bones. Good news for tomato lovers: scientists say two glasses of tomato juice a day can keep osteoporosis away! With more than three million people suffering from the illness in UK, it is definitely some good news to the week bones of Britons. The adult human skeleton undergoes constant remodeling, with new bone forming at sites that have been broken down by a precise process called resorption. A drug marketed to grow bone in osteoporosis patients also works to heal bone wounds in gum disease patients, a University of Michigan study suggests. A new report issued by the International Osteoporosis Foundation (IOF) for World Osteoporosis Day puts the spotlight on the severe impact of spinal fractures and calls on health professionals to recognize the signs of these fractures in their patients. Vitamin D deficiency puts patients with Inflammatory Bowel Disease (IBD) at greater risk of osteoporosis, osteopenia and an overall higher rate of abnormal bone density, according to the results of a new study unveiled today at the American College of Gastroenterology's (ACG) 75th Annual Scientific meeting in San Antonio, Texas. Since 2002, the U.S. Preventive Services Task Force has recommended that women ages 65 and older be routinely screened for osteoporosis and has suggested that a 2-year screening interval might be appropriate. Taking drugs to prevent bone breakage may actually increase the chances for an unusual type of thigh bone fracture, Food and Drug Administration officials warned Wednesday. The U.S. Food and Drug Administration today warned patients and health care providers about the possible risk of atypical thigh bone (femoral) fracture in patients who take bisphosphonates, a class of drugs used to prevent and treat osteoporosis. A labeling change and Medication Guide will reflect this risk.